Absci's stock soars in public debut, as first trade values company at more than $TK billion

This post was originally published on this site

Absci Corp. received a warm reception on Wall Street Thursday, as the shares of the Washington-based provider of an artificial intelligence-powered drug creation platform opened 31.2% above the initial public offering price. The company said overnight that the IPO priced at $16 a share (link), which was in the middle of the expected range (link) of between $15 and $17 a share. The stock’s first trade was at $21.00 at 12:13 p.m. Eastern for 358,014 shares. At that price, Absci was valued at $1.90 billion. The stock’s strong opening occurred on a day that the Renaissance IPO ETF (IPO) fell 0.5% while the S&P 500 eased 0.1%.

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com


(END) Dow Jones Newswires

07-22-21 1233ET

Copyright (c) 2021 Dow Jones & Company, Inc.